AbbVie Inc.'s Allergan unit lost its effort to block two generic-drug makers' copies of Viberzi, as a federal judge canceled six patents for the
See Original Article

HSBC declined to comment on the Bloomberg report. Cowper-Coles told a closed-door event in June that Britain would often bow to the demands of
See Original Article